美国 · SEC FORM 4
GLOBUS MEDICAL INC
GMED · NYSE · CIK 0001237831 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
9 同一窗口内观察到的 Form 4 交易行
3 sales · 6 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2020-08-24 · Douglas Robert Andrew.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 8,437,114
- 上期报告
- 6,767,512
- 日均成交量
- 1,640,932
- 回补天数
- 5.1
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2020-08-24 | Douglas Robert Andrew | 买入 (P) | Class A Common Stock | 615 | USD 53.88 | USD 33,136 | SEC 申报 ↗ |
| 2020-07-22 | Douglas Robert Andrew | 买入 (P) | Class A Common Stock | 690 | USD 47.75 | USD 32,948 | SEC 申报 ↗ |
| 2020-06-22 | Douglas Robert Andrew | 买入 (P) | Class A Common Stock | 700 | USD 48.20 | USD 33,740 | SEC 申报 ↗ |
Form 4 申报证据
31 transaction lines in the latest 365-day window; 181 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | TOBIN JAMES R | 卖出 (S) | Class A Common Stock | 30,000 | USD 74.58 | USD 2,237,400 | SEC 申报 ↗ |
| 2026-09-15 | TOBIN JAMES R | 期权行权／转换 (M) | Class A Common Stock | 30,000 | USD 58.72 | USD 1,761,450 | SEC 申报 ↗ |
| 2026-08-18 | ZARRILLI STEPHEN T | 卖出 (S) | Class A Common Stock | 25,000 | USD 87.04 | USD 2,176,000 | SEC 申报 ↗ |
展开近期 Form 4 证据 (27 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | TOBIN JAMES R | 卖出 (S) | Class A Common Stock | 30,000 | USD 74.58 | USD 2,237,400 | SEC 申报 ↗ |
| 2026-09-15 | TOBIN JAMES R | 期权行权／转换 (M) | Class A Common Stock | 30,000 | USD 58.72 | USD 1,761,450 | SEC 申报 ↗ |
| 2026-08-18 | ZARRILLI STEPHEN T | 卖出 (S) | Class A Common Stock | 25,000 | USD 87.04 | USD 2,176,000 | SEC 申报 ↗ |
| 2026-08-18 | ZARRILLI STEPHEN T | 期权行权／转换 (M) | Class A Common Stock | 25,000 | USD 53.27 | USD 1,331,750 | SEC 申报 ↗ |
| 2026-07-27 | Davidar David D | 赠与 (G) | Class A Common Stock | 2,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | Davidar David D | 卖出 (S) | Class A Common Stock | 25,000 | USD 80.76 | USD 2,019,000 | SEC 申报 ↗ |
| 2026-06-05 | Davidar David D | 期权行权／转换 (M) | Class A Common Stock | 25,000 | USD 26.27 | USD 656,750 | SEC 申报 ↗ |
| 2026-06-04 | RHOADS ANN D | 期权行权／转换 (M) | Class A Common Stock | 25,000 | USD 26.27 | USD 656,750 | SEC 申报 ↗ |
| 2026-02-25 | Huller Kelly | 卖出 (S) | Class A Common Stock | 20,000 | USD 94.50 | USD 1,890,000 | SEC 申报 ↗ |
| 2026-02-25 | Huller Kelly | 期权行权／转换 (M) | Class A Common Stock | 20,000 | USD 43.58 | USD 871,600 | SEC 申报 ↗ |
| 2026-02-12 | Huller Kelly | 卖出 (S) | Class A Common Stock | 10,000 | USD 87.67 | USD 876,700 | SEC 申报 ↗ |
| 2026-02-12 | Huller Kelly | 期权行权／转换 (M) | Class A Common Stock | 10,000 | USD 45.64 | USD 456,400 | SEC 申报 ↗ |
| 2026-01-08 | Norwalk Leslie V | 卖出 (S) | Class A Common Stock | 2,000 | USD 101.10 | USD 202,200 | SEC 申报 ↗ |
| 2026-01-08 | Kline Kyle | 卖出 (S) | Class A Common Stock | 3,594 | USD 101.10 | USD 363,353 | SEC 申报 ↗ |
| 2026-01-08 | Kline Kyle | 期权行权／转换 (M) | Class A Common Stock | 3,594 | USD 51.87 | USD 186,421 | SEC 申报 ↗ |
| 2025-12-12 | Norwalk Leslie V | 卖出 (S) | Class A Common Stock | 4,000 | USD 88.85 | USD 355,400 | SEC 申报 ↗ |
| 2025-12-08 | Paul David C | 期权行权／转换 (M) | Class A Common Stock | 34,375 | USD 25.52 | USD 877,250 | SEC 申报 ↗ |
| 2025-12-01 | Kline Kyle | 卖出 (S) | Class A Common Stock | 18,542 | USD 90.00 | USD 1,668,780 | SEC 申报 ↗ |
| 2025-12-01 | Kline Kyle | 期权行权／转换 (M) | Class A Common Stock | 18,542 | USD 59.86 | USD 1,109,876 | SEC 申报 ↗ |
| 2025-11-25 | Huller Kelly | 卖出 (S) | Class A Common Stock | 7,500 | USD 90.00 | USD 675,000 | SEC 申报 ↗ |
| 2025-11-25 | Huller Kelly | 期权行权／转换 (M) | Class A Common Stock | 7,500 | USD 25.96 | USD 194,700 | SEC 申报 ↗ |
| 2025-11-12 | Davidar David D | 卖出 (S) | Class A Common Stock | 25,000 | USD 86.00 | USD 2,150,000 | SEC 申报 ↗ |
| 2025-11-12 | Davidar David D | 期权行权／转换 (M) | Class A Common Stock | 25,000 | USD 25.52 | USD 638,000 | SEC 申报 ↗ |
| 2025-11-11 | ZARRILLI STEPHEN T | 卖出 (S) | Class A Common Stock | 25,000 | USD 84.29 | USD 2,107,250 | SEC 申报 ↗ |
| 2025-11-11 | ZARRILLI STEPHEN T | 期权行权／转换 (M) | Class A Common Stock | 25,000 | USD 44.14 | USD 1,103,500 | SEC 申报 ↗ |
| 2025-11-10 | RHOADS ANN D | 卖出 (S) | Class A Common Stock | 2,000 | USD 85.00 | USD 170,000 | SEC 申报 ↗ |
| 2025-11-07 | RHOADS ANN D | 卖出 (S) | Class A Common Stock | 8,000 | USD 81.00 | USD 648,000 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | GMED |
| CIK | 0001237831 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 181 transaction lines from 2020-05-21 to 2026-09-15 3 P purchase lines · 79 S sale lines · 99 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.